Future of Medicare drug price negotiations under new administration: 5 things to know
(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More
Inflation Reduction Act of 2022
Public Opinion on Prescription Drugs and Their Prices
(By Grace Sparks, Ashley Kirzinger, Alex Montero, Isabelle Valdes, and Liz Hamel for The Kaiser Family Foundation Published: Oct 04,
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read MoreWhat to Know About Medicare Part D Premiums
(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Aug 01, 2024) The Inflation Reduction Act of
Read MorePayment plan for drugs in 2025
One of the many changes the Inflation Reduction Act (IRA) changed is how Medicare recipients can pay for prescription drugs.
Read MorePay attention during the Open Enrollment Period
Although Medicare Open Enrollment is a few months away, it is not too early to learn about changes that may
Read MoreWhere ACA Marketplace Enrollment is Growing the Fastest, and Why
(By Cynthia Cox and Jared Ortaliza for The Kaiser Family Foundation Published: May 16, 2024) In 2024, Affordable Care Act
Read MorePatients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers
(By Arthur Allen for KFF Health News) Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst,
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 31, 2024) The Inflation Reduction Act of 2022 (the Act),
Read MoreThe New Help for Medicare Beneficiaries with High Drug Costs That Few Seem to Know About
(By Juliette Cubanski and Tricia Neuman for the Kaiser Family Foundation Published: Dec 12, 2023) The Inflation Reduction Act of
Read More